Westenbrink, B. Daan

Epicardial fat in heart failure patients with mid-range and preserved ejection fraction

van Woerden, G., Gorter, T. M., Westenbrink, B. D., Willems, T. P., van Veldhuisen, D. J., & Rienstra, M. (2018) · European Journal of Heart Failure

Cardiovascular Disease and AdiposityHeart Failure Treatment and Management

Cited by 265

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction

Withaar, C., Meems, L. M. G., Markousis-Mavrogenis, G., Boogerd, C. J., Silljé, H. H. W., Schouten, E. M., Dokter, M. M., Voors, A. A., Westenbrink, B. D., Lam, C. S. P., et al. (2021) · Cardiovascular Research

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 223

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives

van Woerden, G., van Veldhuisen, D. J., Westenbrink, B. D., de Boer, R. A., Rienstra, M., & Gorter, T. M. (2022) · European Journal of Heart Failure

Cardiovascular Disease and AdiposityHeart Failure Treatment and Management

Cited by 128

Optimal screening for predicting and preventing the risk of heart failure among adults with diabetes without atherosclerotic cardiovascular disease: a pooled cohort analysis

Patel, K. V., Segar, M. W., Klonoff, D. C., Khan, M. S., Usman, M. S., Lam, C. S. P., Verma, S., DeFilippis, A. P., Nasir, K., Bakker, S. J. L., et al. (2024) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 38